Yayınlar & Eserler

Yayın Ağı
Makaleler 51
Tümü (51)
SCI-E, SSCI, AHCI (46)
SCI-E, SSCI, AHCI, ESCI (51)
ESCI (4)
Scopus (49)
TRDizin (6)

1. Subclinical Enthesitis in Children with Chronic Nonbacterial Osteomyelitis

ŞENER S., YILDIZ A. E., BATU AKAL E. D., ATALAY E., BAŞARAN H. Ö., BİLGİNER Y., et al.
TURKISH ARCHIVES OF PEDIATRICS , sa.3, 2025 (ESCI, TRDizin) identifier identifier

2. Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry

Vitale A., Caggiano V., Sbalchiero J., TUFAN A., BATU AKAL E. D., Ragab G., et al.
RHEUMATOLOGY , 2025 (SCI-Expanded, Scopus) identifier identifier

3. Severe haematological involvement in children with systemic lupus erythematosus and clinical associations

Kisaoglu H., ŞENER S., Demirbas K. C., Demir Yigit Y., GARİPÇİN P., Coskun S., et al.
RHEUMATOLOGY , sa.4, ss.2153-2161, 2025 (SCI-Expanded, Scopus) identifier identifier

4. Influence of gender on Behcet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behcet's Disease Registry

Sota J., Ragab G., AlMaglouth I., Lopalco G., TUFAN A., DİRESKENELİ R. H., et al.
JOINT BONE SPINE , sa.2, 2025 (SCI-Expanded, Scopus) identifier identifier

5. Corticosteroid use in PFAPA syndrome: clinical practice data from the JIR-CliPS Survey Study and a comprehensive literature review

BATU AKAL E. D., ŞENER S., Rodrigues M., Vinit C., Hofer F., Laskari K., et al.
RHEUMATOLOGY , 2025 (SCI-Expanded, Scopus) identifier identifier

6. Examination of antinuclear antibody staining patterns and titers in patients with childhood-onset systemic lupus erythematosus

ŞENER S., BATU AKAL E. D., ÜNAL D., BAŞARAN H. Ö., SARIBAŞ Z., BİLGİNER Y., et al.
LUPUS , sa.1, ss.71-78, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

7. Differences and Similarities Between Children and Adults With Rhupus Syndrome

ŞENER S., ÜNAL D., BATU AKAL E. D., KART BAYRAM G. S., FIRLATAN YAZGAN B., KILIÇ L., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , sa.1, 2025 (SCI-Expanded, Scopus) identifier identifier

8. Interleukin (IL)-1/IL-6-Inhibitor-Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses

Saper V. E., Tian L., Verstegen R. H. J., Conrad C. K., Cidon M., Hopper R. K., et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , cilt.12, sa.11, ss.2996-3020, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

9. Impact of serological activity on flare following clinically inactive disease and remission in childhood-onset systemic lupus erythematosus

Kisaoglu H., ŞENER S., ASLAN E., BAŞARAN H. Ö., ŞAHİN S., BİLGİNER Y., et al.
RHEUMATOLOGY , cilt.63, sa.SI2, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

10. The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C

Caorsi R., Consolaro A., Speziani C., Sozeri B., Ulu K., Faugier-Fuentes E., et al.
JOURNAL OF AUTOIMMUNITY , cilt.147, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

11. Treatment with Janus kinase inhibitors in juvenile dermatomyositis: A review of the literature

ŞENER S., ÇAM V., ÖZEN S., BATU AKAL E. D.
Seminars in Arthritis and Rheumatism , cilt.66, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

12. Polyarticular juvenile idiopathic arthritis has a distinct co-inhibitor receptor profile

SAĞ E., BALIK Z., DEMİR S., KAYA AKCA Ü., ŞENER S., KASAP CÜCEOĞLU M., et al.
RHEUMATOLOGY , 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

13. Subclinical enthesitis in enthesitis-related arthritis and sacroiliitis associated with familial Mediterranean fever

ŞENER S., Atalay E., YILDIZ A. E., KASAP CÜCEOĞLU M., BAŞARAN H. Ö., BATU AKAL E. D., et al.
Modern Rheumatology , cilt.34, sa.3, ss.607-613, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

14. Differentiating Multisystem Inflammatory Syndrome in Children from Kawasaki Disease During the Pandemic

ŞENER S., BATU AKAL E. D., Akca Ü. K., ATALAY E., Cüceoğlu M. K., BALIK Z., et al.
Turkish Archives of Pediatrics , cilt.59, sa.2, ss.150-156, 2024 (ESCI, Scopus, TRDizin) identifier identifier identifier

15. Rhupus syndrome in children: A multi-center retrospective cohort study and literature review

Sener S., BATU AKAL E. D., Sahin S., Yildirim D. G., Ekinci M. K., KISAOĞLU H., et al.
Lupus , cilt.33, sa.3, ss.273-281, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

16. A score for predicting colchicine resistance at the time of diagnosis in familial Mediterranean fever: data from the TURPAID registry

BATU AKAL E. D., ŞENER S., Aydin E. A., Aliyev E., Bagrul I., Türkmen Ş., et al.
Rheumatology (United Kingdom) , cilt.63, sa.3, ss.791-797, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

17. Biologic drugs in the treatment of juvenile dermatomyositis: a literature review

ŞENER S., ÇAM V., ÖZEN S., BATU AKAL E. D.
Clinical Rheumatology , cilt.43, sa.2, ss.591-602, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

18. Drug-induced lupus erythematosus in childhood: Case-based review

KAYA AKCA Ü., ŞENER S., BATU AKAL E. D., BALIK Z., BAŞARAN H. Ö., BİLGİNER Y., et al.
Lupus , 2024 (SCI-Expanded, Scopus) identifier identifier identifier

19. Transition of patients with systemic lupus erythematosus from pediatric to adult- oriented rheumatology care

ŞENER S., Yardimci G. K., BATU AKAL E. D., KILIÇ L., Akca U. K., KASAP CÜCEOĞLU M., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , sa.6, ss.1198-1204, 2024 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier

20. Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries

Vitale A., Caggiano V., TUFAN A., Ragab G., BATU AKAL E. D., Portincasa P., et al.
FRONTIERS IN IMMUNOLOGY , cilt.15, 2024 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

21. Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?

BATU AKAL E. D., ŞENER S., BALIK Z., BAYINDIR Y., ÇAM V., KASAP CÜCEOĞLU M., et al.
Clinical Rheumatology , cilt.43, sa.1, ss.415-421, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

22. Serum autoantibodies and the risk of cancer in systemic sclerosis over time Reply

BATU AKAL E. D., ŞENER S., ÖZEN S.
ARTHRITIS & RHEUMATOLOGY , cilt.75, sa.12, ss.2266-2267, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

23. Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever

ŞENER S., ÇAM V., BATU AKAL E. D., KASAP CÜCEOĞLU M., BALIK Z., Aliyev E., et al.
Rheumatology (Oxford, England) , cilt.62, sa.11, ss.3700-3705, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

24. Comparison of Biopsychosocial Characteristics of Children with Juvenile Idiopathic Arthritis According to Common Disease Subtypes

ŞENER S., KARACA N. B., KAŞLI K., ÖZÇADIRCI A., BATU AKAL E. D., BAŞARAN H. Ö., et al.
TURKISH ARCHIVES OF PEDIATRICS , cilt.58, ss.625-630, 2023 (ESCI, Scopus, TRDizin) identifier identifier identifier

25. Treatment with Biologic Drugs in Pediatric Behçet’s Disease: A Comprehensive Analysis of the Published Data

BATU AKAL E. D., ŞENER S., ÇAM V., Aktay Ayaz N., ÖZEN S.
BioDrugs , cilt.37, sa.6, ss.813-828, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

26. Rice bodies in children with rheumatic disorders: A case series and systematic literature review

ŞENER S., Tanali G., ERGEN F. B., KASAP CÜCEOĞLU M., BALIK Z., BAYINDIR Y., et al.
MODERN RHEUMATOLOGY , cilt.33, ss.811-816, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

27. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: A multicenter study

Kısaarslan A. P., Çiçek S. Ö., BATU AKAL E. D., Şahin S., Gürgöze M. K., Çetinkaya S. B., et al.
Joint Bone Spine , cilt.90, sa.4, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

28. The Effect of Biologics in the Treatment of Multisystem Inflammatory Syndrome in Children (Mis-C): A Single-Center Propensity-Score-Matched Study †

BAŞARAN H. Ö., BATU AKAL E. D., KAYA AKCA Ü., ATALAY E., KASAP CÜCEOĞLU M., ŞENER S., et al.
Children , cilt.10, sa.6, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

29. The Characteristics of Patients With COVID-19–Associated Pediatric Vasculitis: An International, Multicenter Study

BATU AKAL E. D., ŞENER S., Ozomay Baykal G., Arslanoglu Aydin E., Özdel S., Gagro A., et al.
Arthritis and Rheumatology , cilt.75, sa.4, ss.499-506, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

30. Predicting the Need for Additional Immunosuppressive Treatment in Pediatric Behçet’s Patients Pediatrik Behçet Hastalarında Ek İmmünsüpresif Tedavi Gereksiniminin Tahmin Edilmesi

ŞENER S., Dalarslan S., BATU AKAL E. D.
Guncel Pediatri , cilt.21, sa.1, ss.43-51, 2023 (ESCI, Scopus) Creative Commons License identifier identifier

31. Cardiac involvement and cardiovascular risk factors in pediatric primary systemic vasculitides

ŞENER S., Aydin E. A., BATU AKAL E. D.
CLINICAL RHEUMATOLOGY , cilt.42, sa.3, ss.673-686, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

32. Report of 2 pediatric cases with atypical Cogan's syndrome and a systematic review

KASAP CÜCEOĞLU M., BAŞARAN H. Ö., BATU AKAL E. D., Kaya Akca U., Atalay E., ŞENER S., et al.
International Journal of Rheumatic Diseases , cilt.26, sa.3, ss.544-550, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

33. A new tool supporting the diagnosis of childhood-onset Behcet's disease: venous wall thickness

ATALAY E., OĞUZ B., ŞENER S., ÖZCAN H. N., SAĞ E., KAYA AKCA Ü., et al.
RHEUMATOLOGY , cilt.62, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

34. Early-onset juvenile dermatomyositis: A tertiary referral center experience and review of the literature

ŞENER S., BAŞARAN H. Ö., BATU AKAL E. D., Sag E., Oz S., TALİM B., et al.
Seminars in Arthritis and Rheumatism , cilt.58, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

35. A Child with Refractory and Relapsing Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Myopathy: Case-Based Review

ŞENER S., BATU AKAL E. D., SARI S., KASAP CÜCEOĞLU M., YILDIZ A. E., TALİM B., et al.
Journal of neuromuscular diseases , cilt.10, sa.2, ss.279-291, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

36. Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods

AKÇA Ü. K., Tanalı G., Batu E. D., ATALAY E., CU CEOG LU M. s. e. K., ŞENER S., et al.
Turkish archives of pediatrics (Online) , cilt.58, sa.1, ss.49-55, 2023 (TRDizin) identifier identifier identifier

37. Reply on: COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis

BATU AKAL E. D., ŞENER S., ÖZEN S.
Seminars in Arthritis and Rheumatism , cilt.57, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

38. Treatment of childhood-onset Takayasu arteritis: switching between anti-TNF and anti-IL-6 agents

ŞENER S., BAŞARAN H. Ö., KAYA AKCA Ü., ATALAY E., KASAP CÜCEOĞLU M., BALIK Z., et al.
RHEUMATOLOGY , cilt.61, ss.4885-4891, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

39. Bradypnea in a child taking tumor necrosis factor-alpha inhibitors

ŞENER S., BAŞARAN H. Ö., BİLGİNER Y., Kiper N., ÖZEN S.
PEDIATRIC PULMONOLOGY , cilt.57, sa.9, ss.2267-2268, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

40. COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis

BATU AKAL E. D., ŞENER S., ÖZEN S.
SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.55, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

41. IgG4-related disease in pediatric patients: a single-center experience.

KAYA AKCA Ü., ATALAY E., Cuceoglu M., ŞENER S., BALIK Z., BAŞARAN H. Ö., et al.
Rheumatology international , cilt.42, sa.7, ss.1177-1185, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

42. The performances of the ILAR, ASAS, and PRINTO classification criteria in ERA patients: a comparison study

KAYA AKCA Ü., BATU AKAL E. D., ŞENER S., BALIK Z., KASAP CÜCEOĞLU M., ATALAY E., et al.
CLINICAL RHEUMATOLOGY , cilt.41, sa.6, ss.1785-1792, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

43. The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study

Sozeri B., Ulu K., KAYA AKCA Ü., HAŞLAK F., PAÇ KISAARSLAN A., Otar-Yener G., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.42, sa.3, ss.469-475, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

44. Two siblings with Majeed syndrome and neutropenia

KASAP CÜCEOĞLU M., BATU AKAL E. D., YILDIZ A. E., Kaya Akca U., Atalay E., ŞENER S., et al.
Archives of Rheumatology , cilt.37, sa.4, ss.638-640, 2022 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

45. Wind of Change in the Treatment of Childhood-Onset Takayasu Arteritis: a Systematic Review

ŞENER S., BAŞARAN H. Ö., ÖZEN S.
CURRENT RHEUMATOLOGY REPORTS , cilt.23, sa.8, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

46. Systematic review of childhood-onset polyarteritis nodosa and DADA2

Kasap Cuceoglu M., Sener S., Batu E. D., Kaya Akca U., Demir S., Sag E., et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM , cilt.51, sa.3, ss.559-564, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

47. Clinical factors affecting treatment change in chronic hepatitis B infection

ŞENER Y. Z., Sener S.
INTERNAL MEDICINE JOURNAL , cilt.50, sa.8, ss.1027, 2020 (SCI-Expanded, Scopus) identifier identifier

48. Predicting Recurrent Thromboembolism in Atrial Fibrillation

ŞENER Y. Z., OKŞUL M., Sener S.
ANGIOLOGY , cilt.71, sa.4, ss.383, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

49. Membranous nephropathy and cardiovascular events

ŞENER Y. Z., OKŞUL M., Sener S.
INTERNAL MEDICINE JOURNAL , cilt.50, sa.2, ss.259-260, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

50. Factors Related With Outcomes in Patients With Intracardiac Thrombus

ŞENER Y. Z., Sener S.
JOURNAL OF INTENSIVE CARE MEDICINE , 2019 (SCI-Expanded, Scopus) identifier identifier identifier

51. Effects of anticoagulants on protein C activity

ŞENER Y. Z., OKŞUL M., Sener S.
ACTA CARDIOLOGICA , 2019 (SCI-Expanded, Scopus) identifier identifier identifier
Metrikler

Yayın

51

Yayın (WoS)

51

Yayın (Scopus)

49

Atıf (WoS)

11

H-İndeks (WoS)

2

Atıf (Scopus)

92

H-İndeks (Scopus)

6

Atıf (Scholar)

34

H-İndeks (Scholar)

2

Proje

1

Açık Erişim

6
BM Sürdürülebilir Kalkınma Amaçları